Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11598611.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tissue plasminogen activator was used to treat 228 children with 320 central venous catheter (CVC) occlusion events. Patency was restored in 91% of CVCs after 1 to 3 treatments, with no adverse events. Tissue plasminogen activator is effective in restoring patency to occluded CVCs and is a viable alternative to CVC removal or urokinase treatment.
Medical subject headings
- Catheterization, Central Venous
- Fibrinolytic Agents
- Recombinant Proteins
- Thrombosis
- Tissue Plasminogen Activator